Showing results (11-20 of 16) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Antiviral Chemistry & Chemotherapy|July 20, 2000
In vitro anti-HIV-1 activity of sn-2-substituted 1-O-octadecyl-sn-glycero-3-phosphonoformate analogues and synergy with zidovudineK Y Hostetler, J L Hammond, G D Kini, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2005
DX5/CD49b-positive T cells are not synonymous with CD1d-dependent NKT cellsDaniel G Pellicci, Kirsten J L Hammond, Jonathan Coquet, et al.European Journal of Immunology|June 18, 2003
Intrathymic NKT cell development is blocked by the presence of alpha-galactosylceramideDaniel G Pellicci, Adam P Uldrich, Konstantinos Kyparissoudis, et al.Antimicrobial Agents and Chemotherapy|May 17, 2001
Alkylglycerol prodrugs of phosphonoformate are potent in vitro inhibitors of nucleoside-resistant human immunodeficiency virus type 1 and select for resistance mutations that suppress zidovudine resistanceJ L Hammond, D L Koontz, H Z Bazmi, et al.Proceedings of the National Academy of Sciences of the United States of America|August 12, 2004
The T cell antigen receptor expressed by Valpha14i NKT cells has a unique mode of glycosphingolipid antigen recognitionStéphane Sidobre, Kirsten J L Hammond, Lise Bénazet-Sidobre, et al.The Journal of Experimental Medicine|June 18, 2003
NIK-dependent RelB activation defines a unique signaling pathway for the development of V alpha 14i NKT cellsDirk Elewaut, Raziya B Shaikh, Kirsten J L Hammond, et al.Pageof 2